Now time for some of today's trending tickers. We are watching AMD and Intuitive Surgical. Joining me now, we've got the co-host of Market Domination, Josh Lipton. Josh, let's set the scene for folks first with AMD here. AMD's price target raised to $120 a share from $100 at City. This is ahead of the company's advancing AI day. The firm expects the chip maker to launch its latest AI products later this week and highlight some new customers. Overall analysts expect positive catalyst for AMD heading into the second half of the year, highlighting where the chip maker has some advantages over Nvidia potentially here, Josh.

So the interesting about this note, Brad, was they found a lot of good stuff potentially coming for Lisa Su's company, right? I mean, you read through this note. First of all, I thought it was interesting they highlight, hey, it's not just Apple. They're not the only ones with a big tech event this week, right? This is going to be the advancing AI day on June 12th. They expect AMD to launch its latest AI product, highlight new customers, maybe some AWS, maybe even potentially open AI. That would be exciting. They argue AMD does have a few advantages over Nvidia. I thought this part of the note was really interesting. They argue AMD's latest AI product will feature more HBM. They're referring there to high bandwidth memory versus Nvidia's B200 series with substantially lower pricing. Then they talk about even some maybe positive surprises coming up, Brad. They tell their clients about the AI business should ramp for instance in the second half of the year. AMD's Xilinx business, they said should recover. All sounds very exciting, but at the end of the day, they do reiterate a neutral on this one. So they did raise their target as you noted to 120, but they stay on the sidelines. How come? Well, one reason is, they tell clients, quote, we would like more details on AI gross margins and revenue guidance. So they want more financial details, more insight, more info before they would get more bullish.

Yeah, shares moving higher right now. 4% will be watching to see what the announcements are. Plus we mentioned Intuitive Surgical. Let's get into that one. Getting a downgrade to sell from hold at Deutsche Bank, citing quote, significant risks to the company's instruments and accessories business here. Taking a look at shares down right now by just shy of 7% right now.

Yeah, they get slashed to a sell over there at Deutsche Bank. So they're no longer fans. They're on the sidelines. They say we expect a growing number of Intuitive's customers to explore adoption of remanufactured instruments, given the potentially significant profitability gains. They say about 46% of Intuitive's US INA revenues would be at risk of encroachment by these third-party remanufactured devices. When is this going to be potentially a problem, Brad? Deutsche Bank telling their clients our model assumes no material impact in 2026, but steadily increasing headwinds in 2027 and especially 2028. So they do go to a sell. They do slash their target by the way to 440. Now, most on the street are actually still bullish on the name and they like this thing. There are only two sells, but as we know, that does not mean they're wrong.

Yeah, they say within this, about 46% of Intuitive's US INA revenues would be at risk of encroachment by third-party manufactured devices.

Not what you want to hear.

No, not at all. Josh, thanks so much.

Got it.